Dense mapping of MYH9 localizes the strongest kidney disease associations to the region of introns 13 to 15
暂无分享,去创建一个
C. Winkler | P. An | C. Langefeld | D. Bowden | B. Freedman | P. Hicks | J. Kopp | Randall C. Johnson | Meredith A. Bostrom | G. Nelson
[1] S. Rosset,et al. African ancestry allelic variation at the MYH9 gene contributes to increased susceptibility to non-diabetic end-stage kidney disease in Hispanic Americans , 2010, Human molecular genetics.
[2] C. Winkler,et al. Non-muscle myosin heavy chain 9 gene MYH9 associations in African Americans with clinically diagnosed type 2 diabetes mellitus-associated ESRD. , 2009, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[3] Yongmei Liu,et al. Polymorphisms in the non-muscle myosin heavy chain 9 gene (MYH9) are strongly associated with end-stage renal disease historically attributed to hypertension in African Americans. , 2009, Kidney international.
[4] A. Greinacher,et al. MYH9-related platelet disorders. , 2009, Seminars in thrombosis and hemostasis.
[5] M. Leppert,et al. Polymorphisms in the Nonmuscle Myosin Heavy Chain 9 Gene (MYH9) Are Associated with Albuminuria in Hypertensive African Americans: The HyperGEN Study , 2009, American Journal of Nephrology.
[6] M. Nalls,et al. Reduced Neutrophil Count in People of African Descent Is Due To a Regulatory Variant in the Duffy Antigen Receptor for Chemokines Gene , 2009, PLoS genetics.
[7] B. Freedman,et al. Hypertension-associated kidney disease: perhaps no more. , 2008, Journal of the American Society of Nephrology : JASN.
[8] D. Reich,et al. MYH9 is associated with nondiabetic end-stage renal disease in African Americans , 2008, Nature Genetics.
[9] D. Vlahov,et al. MYH9 is a major-effect risk gene for focal segmental glomerulosclerosis , 2008, Nature Genetics.
[10] V. Bellizzi,et al. [Prevalence of chronic kidney disease]. , 2008, Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia.
[11] C. Langefeld,et al. Genome‐wide linkage scans for renal function and albuminuria in Type 2 diabetes mellitus: the Diabetes Heart Study , 2008, Diabetic medicine : a journal of the British Diabetic Association.
[12] J. Coresh,et al. Prevalence of chronic kidney disease in the United States. , 2007, JAMA.
[13] Zhaohui S. Qin,et al. A second generation human haplotype map of over 3.1 million SNPs , 2007, Nature.
[14] Lise Getoor,et al. SplicePort—An interactive splice-site analysis tool , 2007, Nucleic Acids Res..
[15] B. Freedman,et al. Familial Clustering of Chronic Kidney Disease , 2007, Seminars in dialysis.
[16] D. Reich,et al. Principal components analysis corrects for stratification in genome-wide association studies , 2006, Nature Genetics.
[17] R. Ravazzolo,et al. Non-muscle myosin heavy chain IIA and IIB interact and co-localize in living cells: relevance for MYH9-related disease. , 2006, International journal of molecular medicine.
[18] Mark Daly,et al. Haploview: analysis and visualization of LD and haplotype maps , 2005, Bioinform..
[19] M. Olivier. A haplotype map of the human genome. , 2003, Nature.
[20] M. Olivier. A haplotype map of the human genome , 2003, Nature.
[21] C. Hoggart,et al. Design and analysis of admixture mapping studies. , 2004, American journal of human genetics.
[22] M. Daly,et al. Methods for high-density admixture mapping of disease genes. , 2004, American journal of human genetics.
[23] Mark D Shriver,et al. Control of confounding of genetic associations in stratified populations. , 2003, American journal of human genetics.
[24] S. Gabriel,et al. The Structure of Haplotype Blocks in the Human Genome , 2002, Science.
[25] L. Excoffier,et al. Maximum-likelihood estimation of molecular haplotype frequencies in a diploid population. , 1995, Molecular biology and evolution.